Structure/activity relationships of M2 muscarinic allosteric modulators

被引:41
作者
Mohr, K
Tränkle, C
Holzgrabe, U
机构
[1] Univ Bonn, Inst Pharm, D-53121 Bonn, Germany
[2] Univ Wurzburg, Inst Pharm, Wurzburg, Germany
关键词
allosteric modulators; M-2-subtype; muscarinic receptors; review; SARs; CARACURINE-V DERIVATIVES; BIS-AMMONIUM COMPOUND; LIGAND-BINDING; ACETYLCHOLINE-RECEPTORS; POSITIVE COOPERATIVITY; SUBTYPE SELECTIVITY; HEPTANE-1,7-BIS(DIMETHYL-3-PHTHALIMIDOPROPYL)AMMONIUM BROMIDE; ANTAGONIST BINDING; HIGH-AFFINITY; COMMON SITE;
D O I
10.1080/10606820308264
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Allosteric modulation of G protein-coupled receptors has been intensively studied at muscarinic acetylcholine receptors. Findings made with archetypal allosteric agents such as gallamine, alcuronium, and bis(ammonio) alkane-type agents revealed that binding of orthosteric ligands that attach to the acetylcholine site can be allosterically decreased or increased or left unaltered in a subtype-selective fashion. Analyses of structure/activity relationships (SARs) help to elucidate the molecular events underlying the allosteric action and they may pilot the development of new allosteric agents with improved properties and therapeutic perspectives. With a focus on SARs, this review illustrates the principles of muscarinic allosteric interactions, gives an overview of SARs in congeners of archetypal allosteric agents, and considers the topology of M-2 muscarinic allosteric interactions that are characterized by divergent binding modes.
引用
收藏
页码:229 / 240
页数:12
相关论文
共 89 条
[1]  
BEJEUHR G, 1992, PHARM PHARM LETT, V2, P100
[2]   Probing the size of a hydrophobic binding pocket within the allosteric site of muscarinic acetylcholine M2-receptors [J].
Bender, W ;
Staudt, M ;
Tränkle, C ;
Mohr, K ;
Holzgrabe, U .
LIFE SCIENCES, 2000, 66 (18) :1675-1682
[3]   NOTIZ ZUR SYNTHESE DES C-TOXIFERINS-I AUS WIELAND-GUMLICH-ALDEHYD - TOXIZITATSVERGLEICH BEI SYNTHETISCHEN UND NATURLICHEN CURARE-ALKALOIDEN .38. UBER CALEBASSEN-ALKALOIDE [J].
BERLAGE, F ;
BERNAUER, K ;
VONPHILIPSBORN, W ;
WASER, P ;
SCHMID, H ;
KARRER, P .
HELVETICA CHIMICA ACTA, 1959, 42 (01) :394-397
[4]  
Birdsall NJM, 1996, PROG BRAIN RES, V109, P147
[5]  
BOTERO C, 1994, J MED CHEM, V37, P1439
[6]   Effects of brucine, a plant alkaloid, on M1 muscarinic receptors and α1-adrenoceptors in the rabbit vas deferens preparation [J].
Bradley, KN ;
Rowan, EG ;
Harvey, AL .
TOXICON, 2001, 39 (04) :581-587
[7]   Allosteric site on muscarinic acetylcholine receptors: A single amino acid in transmembrane region 7 is critical to the subtype selectivities of caracurine V derivatives and alkane-bisammonium ligands [J].
Buller, S ;
Zlotos, DP ;
Mohr, K ;
Ellis, J .
MOLECULAR PHARMACOLOGY, 2002, 61 (01) :160-168
[8]   CHARACTERIZATION OF THE ANTIMUSCARINIC EFFECT OF HEPTANE-1,7-BIS-(DIMETHYL-3'-PHTHALIMIDOPROPYL AMMONIUM BROMIDE) [J].
CHOO, LK ;
MITCHELSON, F .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 162 (03) :429-435
[9]   Characterization of the subtype selectivity of the allosteric modulator heptane-1,7-bis-(dimethyl-3′-phthalimidopropyl) ammonium bromide (C7/3-phth) at cloned muscarinic acetylcholine receptors [J].
Christopoulos, A ;
Sorman, JL ;
Mitchelson, F ;
El-Fakahany, EE .
BIOCHEMICAL PHARMACOLOGY, 1999, 57 (02) :171-179
[10]   BINDING OF THE MUSCARINE RECEPTOR ANTAGONIST HEPTANE-1,7-BIS(DIMETHYL-3'-PHTHALIMIDOPROPYL)AMMONIUM BROMIDE AT CHOLINOCEPTOR SITES [J].
CHRISTOPOULOS, A ;
LOIACONO, R ;
MITCHELSON, F .
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1993, 246 (01) :1-8